Log In
Print
BCIQ
Print
Print this Print this
 

AGS-003

  Manage Alerts
Collapse Summary General Information
Company Argos Therapeutics Inc.
DescriptionSecond-generation RNA-loaded autologous dendritic cell immunotherapy
Molecular Target Not applicable
Mechanism of ActionImmunotherapy
Latest Stage of DevelopmentPhase III
IndicationRenal cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today